» » Angiotensin-Converting Enzyme Inhibitors: Scientific Basis for Clinical Use

Free eBook Angiotensin-Converting Enzyme Inhibitors: Scientific Basis for Clinical Use download

by Lionel H. Opie

Free eBook Angiotensin-Converting Enzyme Inhibitors: Scientific Basis for Clinical Use download ISBN: 0471111953
Author: Lionel H. Opie
Publisher: Wiley-Liss; 2 edition (December 20, 1994)
Language: English
Pages: 309
Category: Medicine
Subcategory: Medicine
Size MP3: 1939 mb
Size FLAC: 1739 mb
Rating: 4.2
Format: txt azw lit mbr


About the Book ACE inhibitors are justly regarded as the most important advance in cardiac drug therapy since the advent of. .

About the Book ACE inhibitors are justly regarded as the most important advance in cardiac drug therapy since the advent of calcium channel antagonist drugs. Acting basically as inhibitors of the renin-angiotensin vasoconstrictor system. The major aim of ng Enzyme Inhibitors: Scientific Basis for Clinical Use is to present the clinician with the information needed for the practical and discerning use of ACE inhibitors. When do these agents really work and in what doses? Which claims are based on promotional material and which claims have relevance for the clinician in the practical treatment of hypertension, heart failure or myocardial infarction?

oceedings{nvertingEI, title {ng enzyme . The Allen Institute for AIProudly built by AI2 with the help of our. Collaborators.

Opie Wiley-Liss, Bognor, UK, 1994; 316 p. stg£26.

Author: Opie, Lionel H. ISBN . ISBN: 9780471111955. Authors' Pub. House, c1994.

ng enzyme inhibitors. scientific basis for clinical use. by Opie, Lionel H.

Opie, Lionel H. ng enzyme inhibitors.

Condition: Used: Good. Shows some signs of wear, and may have some markings on the inside. 100% Money Back Guarantee. Your purchase also supports literacy charities.

It is envisioned that an updated and detailed understanding of ACE inhibitors and ARBs will facilitate their successful use in the treatment of heart failure, myocardial . ng Enzyme ic use. Arrhythmias, Cardiac/drug therapy. Heart Failure/drug therapy.

It is envisioned that an updated and detailed understanding of ACE inhibitors and ARBs will facilitate their successful use in the treatment of heart failure, myocardial infarction, hypertension, renal failure, and diabetic nephropathy. Publication type, MeSH terms, Substances.

The angiotensin converting enzyme (ACE), a component of the rennin angiotensin system, plays a key role in.Angiotensin Converting Enzyme Inhibitors: Scientific Basis for Clinical Use, p. 259. Jan 1992.

The angiotensin converting enzyme (ACE), a component of the rennin angiotensin system, plays a key role in the homeostatic mechanism of mammals, contributing to the maintenance of normal blood pressure and for the electrolyte balance, being involved in the regulation and control of the arterial pressure. John Wiley and Sons, New York. Basic and Clinical Pharmacology.

About the Book ACE inhibitors are justly regarded as the most important advance in cardiac drug therapy since the advent of calcium channel antagonist drugs. Acting basically as inhibitors of the renin-angiotensin vasoconstrictor system, these agents have grown in importance to become among the therapeutic agents first choice for hypertension and a cornerstone of therapy in congestive heart failure. Recent studies show that they can also prevent overt heart failure and reinfarction, and beneficially influence diabetic renal lesions. The major aim of Angiotensin-Converting Enzyme Inhibitors: Scientific Basis for Clinical Use is to present the clinician with the information needed for the practical and discerning use of ACE inhibitors. When do these agents really work and in what doses? Which claims are based on promotional material and which claims have relevance for the clinician in the practical treatment of hypertension, heart failure or myocardial infarction? This Second Edition adds new material that critically reviews the recent large trials including Consensus-II, Save, V-HeFT-II, Aire, and ISIS-IV and guides the clinician toward a rational policy of use. There is an important new chapter on the use of ACE inhibitors in the metabolic cardiovascular syndrome and in diabetic nephropathy. Reviews of Other Books by the Author Drugs for the Heart--"A gem" (New England Journal of Medicine) The Heart--"The subjects are brilliantly illuminated and made exciting by excellent line diagrams" (The Lancet) Reviews of First Edition of this Book "A new milestone" (British Medical Journal) "Pathophysiology is clarified by numerous diagrams in a style well-known from Opie's former books" (The Lancet)